Matches in Wikidata for { <http://www.wikidata.org/entity/Q80361406> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q80361406 description "article scientifique (publié 2007)" @default.
- Q80361406 description "artikull shkencor i botuar më 01 janar 2007" @default.
- Q80361406 description "artículu científicu espublizáu en xineru de 2007" @default.
- Q80361406 description "im Jahr 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80361406 description "scientific article published on 01 January 2007" @default.
- Q80361406 description "wetenschappelijk artikel" @default.
- Q80361406 description "наукова стаття, опублікована в січні 2007" @default.
- Q80361406 name "In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443)" @default.
- Q80361406 name "In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443)" @default.
- Q80361406 name "In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443)" @default.
- Q80361406 type Item @default.
- Q80361406 label "In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443)" @default.
- Q80361406 label "In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443)" @default.
- Q80361406 label "In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443)" @default.
- Q80361406 prefLabel "In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443)" @default.
- Q80361406 prefLabel "In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443)" @default.
- Q80361406 prefLabel "In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443)" @default.
- Q80361406 P1433 Q80361406-6B021C96-81ED-40D0-AF98-196389EC9D64 @default.
- Q80361406 P1476 Q80361406-A31F4A13-1CC3-4E45-B34F-3E061F74A344 @default.
- Q80361406 P2093 Q80361406-7067E22F-1524-4077-9F9F-B180438CF0A8 @default.
- Q80361406 P2093 Q80361406-72D476E4-0FF3-4FDB-87AA-CEA82F48BE1C @default.
- Q80361406 P2093 Q80361406-E257EC26-3009-4072-BACD-3F5AC7A637AF @default.
- Q80361406 P2093 Q80361406-F01C9B26-9EC8-4E4C-B691-E290911BEE5E @default.
- Q80361406 P304 Q80361406-024D4D02-66F2-4171-B6D5-A15DB6FABBCE @default.
- Q80361406 P31 Q80361406-B782F2A8-04E2-4239-9FA8-F69E2FA85033 @default.
- Q80361406 P356 Q80361406-1445B425-A811-44EF-96DE-D1235400C00B @default.
- Q80361406 P433 Q80361406-35C6C078-29B0-4436-BC53-3000BEC139FB @default.
- Q80361406 P478 Q80361406-2B6722D7-9297-4021-8A50-AC9F2786B8D0 @default.
- Q80361406 P50 Q80361406-2AAD4B02-261F-4C01-BA86-4F08A486F158 @default.
- Q80361406 P577 Q80361406-083DD9FE-D9B7-4CFD-BE2F-1E483177FC95 @default.
- Q80361406 P698 Q80361406-1A615728-2C0F-4BA0-9DDB-8256F006AC96 @default.
- Q80361406 P921 Q80361406-6DA01E88-C47A-4807-8A2B-B60BCE5F2526 @default.
- Q80361406 P356 S-0031-1296608 @default.
- Q80361406 P698 17515292 @default.
- Q80361406 P1433 Q10530143 @default.
- Q80361406 P1476 "In vivo pharmacokinetics and toxicity of a novel hydrophilic oral formulation of the potent non-nucleoside reverse transcriptase inhibitor compound N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea (HI-443)" @default.
- Q80361406 P2093 "Douglas Erbeck" @default.
- Q80361406 P2093 "Heather Tibbles" @default.
- Q80361406 P2093 "Sanjive Qazi" @default.
- Q80361406 P2093 "Taracad K Venkatachalam" @default.
- Q80361406 P304 "218-226" @default.
- Q80361406 P31 Q13442814 @default.
- Q80361406 P356 "10.1055/S-0031-1296608" @default.
- Q80361406 P433 "4" @default.
- Q80361406 P478 "57" @default.
- Q80361406 P50 Q89542817 @default.
- Q80361406 P577 "2007-01-01T00:00:00Z" @default.
- Q80361406 P698 "17515292" @default.
- Q80361406 P921 Q323936 @default.